// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

RTHP-34. CRANIOSPINAL IRRADIATION (CSI) AS PART OF RE-IRRADIATION (RT2) FOR CHILDREN WITH RECURRENT INTRACRANIAL EPENDYMOMA

Derek Tsang - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

RTHP-18. POST-OPERATIVE RADIOTHERAPY FOR PATIENTS WITH FUNCTIONING AND NON-FUNCTIONING PITUITARY ADENOMAS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 7551 CASES

Nardin Samuel - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

RTHP-14. TUMOR-TREATING FIELDS FOR GLIOBLASTOMA: NUMERICAL SIMULATION EXPLORES SUB-CELLULAR MECHANISMS

Kristen Carlson - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

RTHP-07. TRANSCRIPTION FACTOR NETWORKS OF OLIGODENDROGLIOMAS (IDH-MUTANT AND 1p/19q CODELETED) TREATED WITH ADJUVANT RADIOTHERAPY OR OBSERVATION INFORMS PROGNOSIS

Jonathan So - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

QOLP-30. SURVIVAL, LOCAL CONTROL, AND HEALTH RELATED QUALITY OF LIFE IN OLIGOMETASTATIC AND POLYMETASTATIC SPINAL TUMORS: A MULTICENTER, INTERNATIONAL STUDY

Chetan Bettegowda - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

PDTM-12. DLX2 TRANSCRIPTIONAL REGULATION OF CENTRAL NERVOUS SYSTEM CELL FATE RELEVANCE TO PEDIATRIC DIFFUSE MIDLINE GLIOMAS WITH HISTONE 3 MUTATIONS

Mikaela Nevin - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

PDTM-02. STRESS GRANULES ARE INDUCED BY OXIDATIVE STRESS IN PEDIATRIC BRAIN TUMORS AND PREDICT POOR OUTCOME

Alberto Delaidelli - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

PDTM-28. THE CONTRIBUTION OF PAX GENES AS NOVEL TUMOR SUPPRESSORS IN GROUP 3 MEDULLOBLASTOMA

Jamie Zagozewski - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

PDTM-21. MATCHING OF SINGLE CELL TRANSCRIPTOMICS FROM CEREBELLAR DEVELOPMENT IDENTIFIES PUTATIVE SUBGROUP SPECIFIC CELLS OF ORIGIN FOR MEDULLOBLASTOMA

Nada Jabado - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

PDTM-46. POLIOVIRUS RECEPTOR (CD155) EXPRESSION IN PEDIATRIC BRAIN TUMORS MEDIATES ONCOLYSIS OF MEDULLOBLASTOMA AND PLEOMORPHIC XANTHOASTROCYTOMA

Eric Thompson - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

PDTM-45. POSITIVE MODULATION OF NATIVE GABAA RECEPTORS IN MEDULLOBLASTOMA CANCER CELLS WITH BENZODIAZEPINES INDUCES RAPID MITOCHONDRIAL FRAGMENTATION AND TP53-DEPENDENT, CELL CYCLE-INDEPENDENT APOPTOSIS

Maxwell Xu - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

TP53

NIMG-51. THE IMPACT OF FUNCTIONAL MAGNETIC RESONANCE IMAGING ON CLINICAL OUTCOMES IN A PROPENSITY-MATCHED LOW GRADE GLIOMA COHORT

Joseph Megyesi - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

NCOG-01. PRESERVATION OF NEUROCOGNITIVE FUNCTION (NCF) WITH HIPPOCAMPAL AVOIDANCE DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: PRELIMINARY RESULTS OF PHASE III TRIAL NRG ONCOLOGY CC001

Deborah Bruner - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Memantine

PATH-43. RETROSPECTIVE RECLASSIFICATION OF ADULT GLIOMAS FROM A MANITOBA PATIENT COHORT ACCORDING TO THE WHO 2016 GUIDELINES

Amy Norquay - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

PATH-25. SURVIVAL STRATIFICATION OF IDH MUTANT GLIOMA USING METHYLATION AND mRNA ANALYSIS OF HOX GENES

Yasin Mamatjan - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

MNGI-05. DEVELOPMENT AND VALIDATION OF A DNA METHYLOME-BASED PREDICTOR OF MENINGIOMA RECURRENCE AND MENINGIOMA RECURRENCE SCORE

Christel Herold-Mende - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Methadone hydrochloride

MNGI-12. EXPRESSION OF PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) IN MENINGIOMA: CLINICAL UTILITY FOR PREDICTION OF TUMOR RECURRENCE AND ASSOCIATION WITH HYPOXIC RESPONSE AND NFKB2 ACTIVATION

Shirin Karimi - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

MNGI-15. RARE PRESENTATION OF EXTRACRANIAL PARAVERTEBRAL MENINGIOMA IN A CHILD WITH NEUROFIBROMATOSIS TYPE 2: A CASE REPORT

Sapna Oberoi - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Bevacizumab

INNV-28. EXTENT OF RESECTION IN NEWLY DIAGNOSED GLIOBLASTOMA: INCORPORATING CLINICAL AND MOLECULAR DATA TO PREDICT OUTCOME

Julie Semenchuk - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

IMMU-25. PROGRAMMED CELL DEATH-LIGAND 1 (PD-L1) IS NOT EXPRESSED IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TUMOR CELLS

Preet Walia - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Pembrolizumab

Copyright © 2026. QuantiNova All rights reserved